Schedule 13D ownership disclosure

ARROWHEAD PHARMACEUTICALS INC COM

Common stock, par value $0.001 per share (the "Common Stock") · CUSIP: 04280A100

Event date: 2025-02-07

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Sarepta Therapeutics, Inc.Reported CIK 0000873303

    Shares: 11,926,301 · Class: 9.5%

  • Sarepta Therapeutics Investments, Inc.

    Shares: 11,926,301 · Class: 9.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-021481
Form type
SCHEDULE 13D
Filer
ARROWHEAD PHARMACEUTICALS, INC.
CIK
CIK 879407
Filed
Feb 14, 2025
Reporting period
Feb 07, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub